These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 21560153)

  • 1. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the urinary sensation scale (USS).
    Coyne KS; Margolis MK; Hsieh R; Vats V; Chapple CR
    Neurourol Urodyn; 2011 Mar; 30(3):360-5. PubMed ID: 21254195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
    Al-Zahrani AA; Gajewski JB
    BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity.
    Cucchi A; Quaglini S; Rovereto B
    J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
    Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
    BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of urodynamic filling sensation at weekly interval in healthy volunteers and in women with detrusor overactivity.
    Van Meel TD; Wyndaele JJ
    Neurourol Urodyn; 2011 Nov; 30(8):1586-90. PubMed ID: 21538500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women.
    Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T
    Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome.
    Hsiao SM; Lin HH; Kuo HC
    Neurourol Urodyn; 2014 Mar; 33(3):331-4. PubMed ID: 23494586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining urinary urgency: patient descriptions of "gotta go".
    Coyne KS; Harding G; Jumadilova Z; Weiss JP
    Neurourol Urodyn; 2012 Apr; 31(4):455-9. PubMed ID: 22275170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.
    Kuo HC
    Neurourol Urodyn; 2011 Nov; 30(8):1497-502. PubMed ID: 21717501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses.
    Lee SH; Cho ST; Na HR; Ko SB; Park MH
    Int J Urol; 2014 Jul; 21(7):683-7. PubMed ID: 24593278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic Parkinson's disease patients at the urologic clinic.
    Ragab MM; Mohammed ES
    Neurourol Urodyn; 2011 Sep; 30(7):1258-61. PubMed ID: 21404318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.